OR WAIT null SECS
April 19, 2018
The agency has granted breakthrough therapy designation to Roche’s hemophilia therapy for treating hemophilia A in patients without factor VIII inhibitors.
April 16, 2018
Sartorius Stedim Biotech will supply equipment for Penn State’s new Fermentation Facility in the university’s Center of Excellence in Industrial Biotechnology.
April 12, 2018
The new facility, to be built in Toronto, Canada, will significantly increase capacity for pediatric and booster vaccines.
April 11, 2018
The biopharmaceutical firm has chosen Rhode Island as the site of its next-generation biomanufacturing plant, which will offer flexibility, speed, and efficiency.
April 10, 2018
The new 300,000-square-foot facility is considered the largest dedicated cell and gene therapy manufacturing facility with fully integrated services.
April 09, 2018
Roche has acquired a program to develop regenerative therapies for multiple sclerosis.
Under this global collaboration, the companies will develop encapsulated cell therapies for treating Type 1 diabetes.
Celltrion received complete response letters from FDA for its rituximab and trastuzumab biosimilars.
April 06, 2018
Boehringer Ingelheim and OSE Immunotherapeutics have entered a global immuno-oncology partnership to develop a checkpoint inhibitor for treating advanced solid tumors.
April 05, 2018
The companies have created Syna Therapeutics, a joint venture that will develop biosimilars and new molecules.